Ostarine (MK-2866) 25 mg Magnus Pharmaceuticals – instructions for use
Ostarine (MK-2866) 25 mg Magnus Pharmaceuticals is a selective androgen receptor module designed to prevent and treat muscle wasting. This type of SARM not only saves body weight but also increases it. Ostarine is 100% anabolic and an immeasurable androgen. For this reason, its use should lead to an increase in muscle mass.
What are the effects of Ostarine (MK-2866) 25 mg Magnus Pharmaceuticals?
It is a SARM-type product for active muscle growth and fat loss. It increases your strength, endurance and energy. One of the important effects is that Ostarine (MK-2866) 25 mg Magnus Pharmaceuticals is often used as muscle protection during dieting. Therefore, you can lose weight while maintaining the previously gained muscle mass.
Additional effects the drug has:
- increased activity;
- growth of muscle mass;
- increased athletic performance;
- improved metabolism.
With the correct dosage and the correct mode of intake, good results can be achieved.
Side effects and contraindications to take
If used incorrectly, there may be such side effects:
- nausea;
- dizziness;
- skin rash;
- allergic reaction.
This drug is contraindicated in people with heart disease and kidney failure. Please also note that before purchase you need a mandatory medical consultation!
Ostarine (MK-2866) 25mg Magnus Pharmaceuticals dosage schedule, how to take
Ostarine (MK-2866) 25 mg Magnus Pharmaceuticals is used for building high-quality muscle mass, for protection during dieting or for so-called body composition: building muscle while losing fat.
The experience of professional bodybuilders shows that 3-25 mg of Ostarine per day are used during the mass phase in the amateur and professional field.
Since the half-life of Ostarine is 24 hours, the dose used is taken once in the morning. The duration of the course is 12 weeks.
List of references
- “Ostarine: An Investigational Selective Androgen Receptor Modulator (SARM) for the Treatment of Muscle Wasting” by R. Narayanan, M. Coss, and D. D. Yepuru.
- “Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications” by C. F. S. Santos and D. A. Gonçalves.
- “Selective Androgen Receptor Modulators: The Future of Androgen Therapy?” by J. A. Katzenellenbogen and C. M. Muthyala.
- “The Discovery and Development of Selective Androgen Receptor Modulators (SARMs)” by J. T. Dalton.
- “Pharmacokinetics and Pharmacodynamics of Nonsteroidal SARMs in Rats” by M. S. Steiner, R. D. Hess, and D. J. Body.
Reviews
Clear filtersThere are no reviews yet.